Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fresenius Se & Company Kg ADR (FSNUY)

Fresenius Se & Company Kg ADR (FSNUY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fresenius Se & Company Kg ADR Else-Kroner-Strasse 1 Bad Homburg 2M 61352 DEU

www.fresenius.com P: 49-6172-6080

Description:

Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.

Key Statistics

Overview:

Market Capitalization, $K 15,101,901
Enterprise Value, $K 34,081,452
Shares Outstanding, K 2,234,009
Annual Sales, $ 24,011 M
Annual Net Income, $ -639,620 K
Last Quarter Sales, $ 6,006 M
Last Quarter Net Income, $ 175,230 K
EBIT, $ 2,290 M
EBITDA, $ 5,422 M
60-Month Beta 1.13
% of Institutional Shareholders 0.00%
Float, K 2,234,009
% Float 100.00%
Short Volume Ratio 0.20

Growth:

1-Year Return 4.64%
3-Year Return -39.64%
5-Year Return -53.76%
5-Year Revenue Growth -39.36%
5-Year Earnings Growth -8.86%
5-Year Dividend Growth 13.33%

Per-Share Information:

Most Recent Earnings 0.17 on 11/02/23
Latest Earnings Date 05/14/24
Earnings Per Share ttm 0.74
EPS Growth vs. Prev Qtr -5.56%
EPS Growth vs. Prev Year 21.43%
Annual Dividend Rate, $ 0.17
Annual Dividend Yield 2.47%
Most Recent Dividend 0.167 on 05/18/23
Next Ex-Dividends Date 05/18/23
Dividend Payable Date 05/30/23
Dividend Payout Ratio 22.61%
Most Recent Split 3-2 on 08/05/14

FSNUY Ratios

Ratio
Price/Earnings ttm 8.98
Price/Earnings forward 7.62
Price/Earnings to Growth N/A
Return-on-Equity % 4.88%
Return-on-Assets % 2.02%
Profit Margin % -2.66%
Debt/Equity 0.15
Price/Sales 0.62
Price/Cash Flow 3.01
Price/Book 0.45
Book Value/Share 14.75
Interest Coverage 0.00

FSNUY Dividends

Date Value
05/18/23 $0.1670
05/16/22 $0.1620
05/24/21 $0.1820
08/31/20 $0.1680
05/20/19 $0.1490
05/21/18 $0.1470
05/15/17 $0.1120
05/15/13 $0.1790
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar